This company listing is no longer active
METEX Stock Overview
A biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
METabolic EXplorer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.12 |
| 52 Week High | €0.98 |
| 52 Week Low | €0.05 |
| Beta | 1.07 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -58.14% |
| 3 Year Change | -97.67% |
| 5 Year Change | -90.52% |
| Change since IPO | -98.63% |
Recent News & Updates
Recent updates
METabolic EXplorer S.A. (EPA:METEX) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Feb 10
Why Investors Shouldn't Be Surprised By METabolic EXplorer S.A.'s (EPA:METEX) 27% Share Price Plunge
Dec 18Health Check: How Prudently Does METabolic EXplorer (EPA:METEX) Use Debt?
Oct 01News Flash: One METabolic EXplorer S.A. (EPA:METEX) Analyst Has Been Trimming Their Revenue Forecasts
Jul 30Downgrade: The Latest Revenue And EPS Forecasts For METabolic EXplorer S.A. (EPA:METEX)
Jul 10Does METabolic EXplorer (EPA:METEX) Have A Healthy Balance Sheet?
Jun 14Is METabolic EXplorer S.A. (EPA:METEX) Potentially Undervalued?
May 10What Is METabolic EXplorer S.A.'s (EPA:METEX) Share Price Doing?
Jan 25Statutory Earnings May Not Be The Best Way To Understand METabolic EXplorer's (EPA:METEX) True Position
Oct 06METabolic EXplorer (EPA:METEX) Has Debt But No Earnings; Should You Worry?
May 12The METabolic EXplorer (EPA:METEX) Share Price Has Soared 428%, Delighting Many Shareholders
Mar 18Investors Who Bought METabolic EXplorer (EPA:METEX) Shares A Year Ago Are Now Up 74%
Dec 03
Shareholder Returns
| METEX | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -1.7% |
| 1Y | -58.1% | -5.7% | -4.8% |
Return vs Industry: METEX underperformed the French Chemicals industry which returned 12.9% over the past year.
Return vs Market: METEX underperformed the French Market which returned 1.8% over the past year.
Price Volatility
| METEX volatility | |
|---|---|
| METEX Average Weekly Movement | 0% |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine METEX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 450 | Benjamin Gonzalez | www.metabolic-explorer.com |
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials.
METabolic EXplorer S.A. Fundamentals Summary
| METEX fundamental statistics | |
|---|---|
| Market cap | €6.16m |
| Earnings (TTM) | -€49.34m |
| Revenue (TTM) | €168.17m |
0.0x
P/S Ratio-0.1x
P/E RatioIs METEX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| METEX income statement (TTM) | |
|---|---|
| Revenue | €168.17m |
| Cost of Revenue | €174.73m |
| Gross Profit | -€6.56m |
| Other Expenses | €42.78m |
| Earnings | -€49.34m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.97 |
| Gross Margin | -3.90% |
| Net Profit Margin | -29.34% |
| Debt/Equity Ratio | 122.3% |
How did METEX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/09 03:22 |
| End of Day Share Price | 2024/10/09 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
METabolic EXplorer S.A. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charles-Louis Planade | Arkeon Finance |
| Arsene Guekam | CIC Market Solutions (ESN) |
| Charles Bordes | Kepler Cheuvreux |